This epidemiological study was carried out as a 3-year follow-up project to assess the incidence of transient ischemic attacks (TIAs) and strokes; 8,846 treated hypertensive patients (mean BP, 149/84 mm Hg) aged 65 years or over (mean age, 73.7 ± 6.3 years), devoid of symptoms of dementia and with documented vascular risk factors were recruited from January 1994 to August 1995, by 1,598 general practitioners in connection with 36 referral university neurology units throughout metropolitan France. Among these patients, 506 (5.7%) had at least one cerebrovascular event during the follow-up period: 309 (3.5%) experienced one or more isolated TIAs, and 197 (2.2%) had a stroke with or without a preceding TIA. A total of 510 TIAs were reported. The stroke subtypes were ischemia, hemorrhage, and unclassified in 70, 16, and 15% of the cases, respectively. The estimated annual stroke incidence was 7.42‰. Of the 197 patients who developed strokes, 51 (26%) died. This case-fatality rate should be compared with the 4.5% mortality rate observed in the whole population during the study period. The 3 subgroups (with isolated TIAs, strokes, or no events during the study) were found to differ regarding age, sedentary lifestyle, past history of cardiovascular events, duration of hypertension, and evidence of complicated hypertension (univariate analysis). The factors identified as predictive of a stroke (multivariate analysis) were: the patient’s age; sedentary lifestyle; pulse pressure (SBP-DBP); identification of TIA at baseline, and presence of arrhythmias.

Keywords:
Epidemiology, Transient ischemic attack, Stroke, Hypertension, Elderly, Risk factor, Predictive factor, stroke
1.
Sacco RL, Wolf PA, Gorelick PB: Risk factors and their management for stroke prevention: Outlook for 1999 and beyond. Neurology 1999;53(suppl 4):S15–S24.
2.
Shahar E, McGovern PG, Sprafka JM, et al: Improved survival of stroke patients during the 1980s. The Minnesota Stroke Survey. Stroke 1995;26:1–6.
3.
Oxfordshire Community Stroke Project: Incidence of stroke in Oxfordshire: First year’s experience of a community stroke register. BMJ 1983;287:713–717.
4.
Malmgren R, Warlow C, Barford J, Sandercock P: Geographical and secular trends in stroke incidence. Lancet 1987;2:1196–1200.
5.
Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M: Stroke incidence, case fatality, and mortality in the WHO-MONICA Project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke 1995;26:361–367.
6.
Tuomilehto J, Sarti C, Narva EV, et al: The FIN-MONICA stroke register. Community-based stroke registration and analysis of stroke incidence in Finland, 1983–1985. Am J Epidemiol 1992;135:1259–1270.
7.
Bonita R, Anderson CS, Braod JB, Jarnrozik KD, Stewart-Wynne EG, Anderson NE: Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based stroke registers. Stroke 1994;25:552–557.
8.
Giroud M: Incidence et mortalité des accidents vasculaires cérébraux en France. Ann Cardiol Angéiol 1994;43:214–216.
9.
Du X, Sourbutts J, Cruickshank K, Summers A, Roberts N, Walton E, Holmes S: A community-based stroke register in a high-risk area for stroke in north-west England. J Epidemiol Community Health 1997;51:472–478.
10.
Giroud M, Beuriat P, Gisselmann A, Dusserre L, Dumas R: Epidémiologie des accidents vasculaires cérébraux. D’après le registre dijonnais (1985–1988). Presse Méd 1989;18:1103–1106.
11.
D’Anglejan Chatillon J, Bousser MG: Epidémiologie des accidents vasculaires cérébraux. Cœur Santé 1992(special issue):7–8.
12.
Mas JL: Accident ischémique transitoire. Epidémiologie, étiologie, physiopathologie, diagnostic, évolution et pronostic, traitement. Rev Prat 1990;40:2373–2378.
13.
McGovern PG, Burke GL, Sprafka JM, Xue S, Folsom AR, Blackburn H: Trends in mortality, morbidity and risk factor levels for stroke from 1960 through 1990. JAMA 1992;268:753–759.
14.
Wolf PA, D’Agostino RB, O’Neal MA, Sytkowski P, Kase CS, Belanger AI, Kannel WB: Secular trends in stroke incidence and mortality: the Framingham Study. Stroke 1992;23:1551–1555.
15.
Shekelle RB, Ostfeld AM, Klawans HL: Hypertension and risk of stroke in an elderly population. Stroke 1974;5:71–75.
16.
Kannel WB, Dawber TR, Sorlie P, Wolf PA: Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham Study. Stroke 1976;7:327–331.
17.
Lawton MP, Brody EM: Assessment of older people self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
18.
Folstein MF, Folstein SE, McHugh PR: ’Mini Mental State’: A practical method for grading the cognitive state of patients for clinicians. J Psychiatr Res 1975;12:189–198.
19.
Wechsler D: A standardized memory scale for clinical use. J Psychol 1945;19:85–87.
20.
SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255–3264.
21.
Lindenstrøm E, Boysen G, Nyboe J, Appleyard M: Stroke incidence in Copenhagen, 1976–1988. Stroke 1992;23:28–32.
22.
Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al: Effect of angiotensin-converting-enzyme inhibition compared to conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;353:611–616.
23.
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al: Effect of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal treatment (HOT) randomised trial. Lancet 1998;351:1755–1762.
24.
Ahmed OI, Orchard TJ, Sharma R, Mitchell H, Talbot E: Declining mortality from stroke in Allegeny County, Pennsylvania: Trends in case-fatality and severity of disease, 1971–1980. Stroke 1988;19:181–184.
25.
Stegmayer B, Asplund K, Wester PO: Trends in incidence, case-fatality rate, and severity of stroke in Northern Sweden, 1985–1991. Stroke 1994;25:1738–1745.
26.
Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke and coronary heart disease. I. Short-term reductions in blood pressure; overview of randomised drug trials in their epidemiological context. Lancet 1990;335:765–774 and 827–838.
27.
Bulpitt CJ, on the behalf of the HYVET investigators: The hypertension in the very elderly trial: The importance of the pilot trial and modifications to the protocol. Eur Heart J 1999;20(suppl):9–12.
28.
Harmsen P, Tsipogianni A, Wilhelmsen L: Stroke incidence rates were unchanged, while fatality rates declined during 1971–1987 in Göteborg, Sweden. Stroke 1992;23:1410–1415.
29.
Garland C, Barrett-Connor E, Suarez L, Criqui MH: Isolated systolic hypertension and mortality after age 60 year. Am J Epidemiol 1983;118:365–376.
30.
Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetière P, et al: Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997;30:1410–1415.
31.
Millar JA, Lever AF, Burke V: Pulse pressure as a risk factor for cardiovascular events in the MRC Mild hypertension trial. J Hypertens 1999;17:1065–1071.
32.
Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JCM, Breteler MMB: J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 1999;34:1181–1185.
33.
Kaplan N: J curve not burned off by HOT study. Lancet 1998;351:1748–1749.
34.
The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413–2446.
35.
Recommandations et références médicales de l’ANAES: Diagnostic et traitement de l’hypertension artérielle essentielle de l’adulte de 20 à 80 ans. J Mal Vasc 1998;23:204–231.
36.
Chamontin B, Poggi L, Lang T, Ménard J, Chevalier H, Gallois H, Crémier O: Prevalence, treatment, and control of hypertension in the French population. Data from a survey on high blood pressure in general practice, 1994. Am J Hypertens 1998;11:759–762.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.